Drugs News and Research

RSS

New experimental antibiotic can help combat MRSA infections

A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA.

14 Jun 2016

Clinical trial to test efficacy of new drug for chronic cough

The National Institute for Health Research has today announced its participation in a clinical trial to test a promising new treatment for chronic cough. If approved, this would be the first new cough drug in 50 years and offer hope to the millions of people living with chronic cough for whom few, if any, effective treatments exist.

14 Jun 2016

New imaging study links tau proteins to neurodegenerative pathology of Alzheimer's disease

Alzheimer's is a devastating and incurable disease marked by beta-amyloid and tau protein aggregations in the brain, yet the direct relationship between these proteins and neurodegeneration has remained a mystery.

14 Jun 2016

Liraglutide drug effectively decreases cardiovascular disease risk in type 2 diabetes patients

Researchers have shown that the glucose-lowering drug liraglutide safely and effectively decreases the overall risk of heart attack, stroke, or cardiovascular death for people with type 2 diabetes.

14 Jun 2016

Scientists find new way to slow growth of triple negative breast cancer

CANCER RESEARCH UK scientists have found a new way to slow the growth of the most aggressive type of breast cancer, according to research published in the journal Oncogene today (Monday).

14 Jun 2016

Study underscores importance of developing PRMT5 inhibitors as promising treatment for GB patients

A new study suggests that blocking an enzyme called PRMT5 in tumor cells could be a promising new strategy for the treatment of glioblastoma (GB), the most aggressive and lethal form of brain cancer.

14 Jun 2016

PET imaging can help identify autoimmune inflammation in MS

The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years, but molecular imaging is bringing researchers closer to identifying them, while providing a means of evaluating next-generation therapies for MS, say researchers introducing a study at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

14 Jun 2016

PET/CT imaging technique may provide way to break perpetual cycle of alcohol abuse

Alcoholism is a devastating disorder that too often leads to a perpetual cycle of abuse. An emerging molecular imaging technique may provide a way to break that cycle.

14 Jun 2016

Novel radioimmunotherapy may help cure colorectal cancer

An emerging cancer therapy has colorectal tumors surrounded. Presenters at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging are unveiling a novel radioimmunotherapy that combines a cancer-seeking antibody with potent radionuclide agents, resulting in complete remission of colorectal cancer in mouse models.

14 Jun 2016

Factors other than just cost may influence prescribing of TNF inhibitors for RA patients

The results of a study presented today at the European League Against Rheumatism Annual Congress showed that a range of factors other than just cost may influence the prescribing of TNF inhibitors for patients with rheumatoid arthritis (RA).

13 Jun 2016

Natural tendency to self-restrict time in bed can protect against chronic insomnia

Twenty to 50 percent of Americans suffer from acute insomnia each year, defined as difficulty falling asleep or staying asleep, three or more nights per week, for between two weeks and three months.

13 Jun 2016

Scientists develop new tool to overcome major hurdle for personalized medicine

Scientists from EPFL and ETHZ have developed a powerful tool for exploring and determining the inherent biological differences between individuals, which overcomes a major hurdle for personalized medicine.

13 Jun 2016

Study sheds light on why many RA patients do not adhere to treatment

Two new studies presented at the European League Against Rheumatism Annual Congress have shed light on why so many patients with Rheumatoid Arthritis (RA) do not adhere to their therapy, even in the early stages of their treatment.

13 Jun 2016

Heart rhythm disorder may increase death risk in motor vehicle accident victims

A study in nearly three million motor vehicle accident victims has found that atrial fibrillation is associated with a higher risk of death.

13 Jun 2016

Using Spectral Imaging to Study Brain Tumors in 3D

I’m a biophysicist at the University of Bordeaux and I mainly work on bio-imaging methods in the cancer laboratory research facility, mostly for brain cancers.

From Daylight Solutions Inc 13 Jun 2016

Sleep disturbing medicines may not contribute to sleep disturbances in general population

Medicines that carry warnings about sleep disturbances do not seem to contribute to the amount of sleep disturbances in the general population, according to new ‘real world’ research.

13 Jun 2016

Postnova reports advances in analysis of plasma proteins using AF4-ICP-MS system

Postnova Analytics reports on exciting advances in the analysis of plasma proteins using a hyphenated system that couples asymmetric flow Field-Flow Fractionation (AF4) and inductively coupled plasma-mass spectrometry.

From Postnova Analytics 13 Jun 2016

PI3K/AKT/mTOR pathway plays key role in prostate tumor growth and progression

The research article - Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy, by Dr Claudio Festuccia and published in Clinical Cancer Drugs, volume 3, issue 1 - discusses experimental and clinical data on the pharmacological inhibition of the Akt/mTOR pathways.

13 Jun 2016

Diabetes-heart disease combination can increase death risk

The combination of type 2 diabetes and coronary artery disease can be deadly. New research from a global study led by a physician from UConn Health has found that patients with Type 2 diabetes admitted into the hospital for congestive heart failure face a one in four chance of dying over the next 18 months.

13 Jun 2016

New research offers more insights into development of Kennedy's disease

Kennedy's disease leads to progressive muscle wastage. It is a condition that affects only men and it appears between 40 and 50 years of age. There is no specific treatment available.

13 Jun 2016

Drugs News and Research

New experimental antibiotic can help combat MRSA infections

Clinical trial to test efficacy of new drug for chronic cough

New imaging study links tau proteins to neurodegenerative pathology of Alzheimer's disease

Liraglutide drug effectively decreases cardiovascular disease risk in type 2 diabetes patients

Scientists find new way to slow growth of triple negative breast cancer

Study underscores importance of developing PRMT5 inhibitors as promising treatment for GB patients

PET imaging can help identify autoimmune inflammation in MS

PET/CT imaging technique may provide way to break perpetual cycle of alcohol abuse

Novel radioimmunotherapy may help cure colorectal cancer

Factors other than just cost may influence prescribing of TNF inhibitors for RA patients

Natural tendency to self-restrict time in bed can protect against chronic insomnia

Scientists develop new tool to overcome major hurdle for personalized medicine

Study sheds light on why many RA patients do not adhere to treatment

Heart rhythm disorder may increase death risk in motor vehicle accident victims

Using Spectral Imaging to Study Brain Tumors in 3D

Sleep disturbing medicines may not contribute to sleep disturbances in general population

Postnova reports advances in analysis of plasma proteins using AF4-ICP-MS system

PI3K/AKT/mTOR pathway plays key role in prostate tumor growth and progression

Diabetes-heart disease combination can increase death risk

New research offers more insights into development of Kennedy's disease

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News